- Home
- ARCT vs EU Comparison
ARCT vs EU Comparison
Compare ARCT & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCT | EU |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 306.9M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ARCT | EU |
|---|---|---|
| Price | $10.29 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $23.80 | $2.83 |
| AVG Volume (30 Days) | 636.5K | ★ 2.6M |
| Earning Date | 11-05-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | 11.76 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | $43,155,000.00 |
| Revenue This Year | N/A | $59.92 |
| Revenue Next Year | $54.47 | $23.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $0.66 |
| 52 Week High | $17.96 | $3.68 |
Technical Indicators
Market Signals| Indicator | ARCT | EU |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 31.56 |
| Support Level | $6.53 | N/A |
| Resistance Level | $12.44 | $1.47 |
| Average True Range (ATR) | 1.07 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 37.25 | 8.30 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.